Try GOLD - Free
Indian Pharma to grow 7-9% in FY26 despite US headwinds: ICRA
The Business Guardian
|September 19, 2025
India’s pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook.

According to ICRA, the growth momentum will be driven by 8-10 percent expansion in the domestic market and 10-12 per cent gains in Europe, while sales in the US are likely to moderate to 3-5 percent, compared with nearly10 per cent growth achieved in FY25.”The domestic market continues to be a key growth driver for Indian pharma companies. Sales force expansion, improved productivity of medical repre-
sentatives, deeper rural distribution, and new product launches are expected to support 8-10 per cent revenue growth in FY2026 in the domestic market,” said Kinjal Shah, Senior Vice President & Co-Group Head ICRA.
This story is from the September 19, 2025 edition of The Business Guardian.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 9,500+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM The Business Guardian

The Business Guardian
‘Capex, Opex subsidies in mineral scheme to boost recycling infra’
Provision of both capital expenditure (Capex) and operational expenditure (Opex) subsidies under Rs 1,500 crore incentive scheme for Critical Mineral Recycling will accelerate the establishment of advanced recycling infrastructure, said industry body India Energy Storage Alliance (IESA) while welcoming the Centre's move.
2 mins
September 21, 2025

The Business Guardian
Why 2 nm chips matter in India’s chip revolution
India has taken another big step in its semiconductor journey with the recent inauguration of ARM's new design office in Bengaluru.
2 mins
September 21, 2025
The Business Guardian
GOVT ACTIVATES PORTAL FOR GST COMPLAINTS
The Ministry of Consumer Affairs, Food & Public Distribution on Saturday announced the activation of a dedicated category on the INGRAM portal to handle anticipated consumer queries and complaints on the National Consumer Helpline (NCH), following the implementation of revised GST charges, rates, and exemptions effective from September 22.
2 mins
September 21, 2025
The Business Guardian
BofA sees positive outlook for Paytm, citing soundbox, AI
Paytm (One97 Communications Limited), India's full stack merchant payments leader, is showing steady momentum across its core
1 min
September 21, 2025

The Business Guardian
GST CUTS TO BOOST ECONOMY, BUT REVENUE LOSS COULD HIT BANKING SECTOR
While the government has estimated an annual revenue loss of about Rs 480 billion, due to the reduced Goods and Services Tax (GST) rates on various products, a recent report by Systematix Research has pegged the figure much higher, at nearly Rs 1.2 trillion.
1 mins
September 21, 2025

The Business Guardian
Ahead of IPO, Ganesh Consumer Products raises Rs 122 crore
Ganesh Consumer Products Ltd, a key player in packaged food products in eastern India, on Friday said it has raised over Rs 122 crore from anchor investors, ahead of its initial share-sale opening for public subscription.
1 min
September 21, 2025

The Business Guardian
Third round of India-New Zealand FTA negotiations concludes
The third round of negotiations for the India-New Zealand Free Trade Agreement (FTA) concluded successfully on Friday in Queenstown, New Zealand.
1 min
September 21, 2025
The Business Guardian
'Capex, Opex subsidies in mineral scheme to boost recycling infra'
Eligible feedstock is e-waste, Lithium Ion Battery (LIB) scrap, and scrap other than e-waste & LIB scrap, e.g. catalytic converters in end-of-life vehicles.
1 min
September 21, 2025

The Business Guardian
Zelio E-Mobility gets Sebi nod for Rs 78-cr IPO
Electric vehicle maker Zelio E-Mobility Ltd on Friday said it has received approval from capital market regulator Sebi for its SME IPO to raise Rs 78 crore.
1 min
September 21, 2025

The Business Guardian
US' H-1B fee move can have ripple effects on US innovation system
Indian IT industry body Nasscom has expressed concerns following the White House’s September 19 announcement of anew USD 100,000 annual fee on H-IB visa applications, calling the move potentially disruptive to global business continuity and the innovation ecosystem in the United States.
2 mins
September 21, 2025
Listen
Translate
Change font size